Adaptive Biotechnologies (ADPT) Free Cash Flow Growth (3y) (2021 - 2026)
Powered by 
Analysis
Adaptive Biotechnologies (ADPT) Free Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 53.76% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 10.52% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 8.16% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 11.42% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 28.22% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 34.71% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 67.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.71% |
| Mar 31, 2026 | 44.99% |
| Dec 31, 2025 | 26.90% |
| Sep 30, 2025 | 45.99% |
| Jun 30, 2025 | 37.01% |
| Mar 31, 2025 | 23.92% |
| Dec 31, 2024 | 41.59% |
| Sep 30, 2024 | 22.14% |
| Jun 30, 2024 | 31.52% |
| Mar 31, 2024 | 18.66% |
| Dec 31, 2023 | 16.91% |
| Sep 30, 2023 | 1.25% |
| Jun 30, 2023 | 6.50% |
| Mar 31, 2023 | -21.55% |
| Dec 31, 2022 | -3.69% |
| Sep 30, 2022 | -12.54% |
| Jun 30, 2022 | -44.12% |
| Mar 31, 2022 | -30.96% |
| Dec 31, 2021 | -99.82% |
| Sep 30, 2021 | -61.14% |